Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia.
Manna A, Aulakh S, Jani P, Ahmed S, Akhtar S, Coignet M, Heckman M, Meghji Z, Bhatia K, Sharma A, Sher T, Alegria V, Malavasi F, Chini EN, Chanan-Khan A, Ailawadhi S, Paulus A. Manna A, et al. Among authors: alegria v. Clin Cancer Res. 2019 Jul 1;25(13):3974-3985. doi: 10.1158/1078-0432.CCR-18-3412. Epub 2019 Apr 2. Clin Cancer Res. 2019. PMID: 30940652 Free PMC article.
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities.
Ailawadhi S, Azzouqa AG, Hodge D, Cochuyt J, Jani P, Ahmed S, Sher T, Roy V, Ailawadhi M, Alegria VR, Manochakian R, Vishnu P, Grover A, Abdulazeez MF, Paulus A, Chanan-Khan A. Ailawadhi S, et al. Among authors: alegria vr. Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):619-623. doi: 10.1016/j.clml.2019.06.010. Epub 2019 Jun 26. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31377212
Monoclonal antibody utilization characteristics in patients with multiple myeloma.
Ailawadhi S, Sher T, Azzouqa AG, Meghji Z, Jain T, Jani P, Ahmed S, Diehl N, Roy V, Shah V, Hodge D, Ailawadhi M, Alegria VR, Paulus A, Chanan-Khan A, Fonseca R. Ailawadhi S, et al. Among authors: alegria vr. Anticancer Drugs. 2019 Sep;30(8):859-865. doi: 10.1097/CAD.0000000000000810. Anticancer Drugs. 2019. PMID: 31415286
Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient Care.
Kumar V, Alhaj-Moustafa M, Bojanini L, Sher T, Roy V, Manochakian R, Vishnu P, Bodepudi S, Shareef Z, Ahmed S, Jani P, Paulus A, Grover A, Alegria VR, Ailawadhi M, Chanan-Khan A, Ailawadhi S. Kumar V, et al. Among authors: alegria vr. JCO Oncol Pract. 2020 Apr;16(4):e341-e349. doi: 10.1200/JOP.19.00309. Epub 2020 Jan 21. JCO Oncol Pract. 2020. PMID: 32048939
28 results